|
Volumn 46, Issue 2, 2006, Pages 158-165
|
Future chemotherapy, with emphasis on bacterial murein
|
Author keywords
Antibiotics; Bacterial wall; Lactam antibiotics; Sacculus
|
Indexed keywords
6 AMINOPENICILLANIC ACID;
ANTIBIOTIC AGENT;
AZTREONAM;
BACTERIAL PROTEIN;
BETA LACTAM ANTIBIOTIC;
BETA LACTAMASE;
CARBAPENEM;
CEFALORIDINE;
CEFALOTIN;
CEFAZOLIN;
CEPHALOSPORIN C;
CEPHALOSPORIN DERIVATIVE;
CEPHALOSPORINASE;
CLAVULANIC ACID;
METICILLIN;
OXACILLIN;
PENICILLIN DERIVATIVE;
PENICILLIN G;
PEPTIDOGLYCAN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
STREPTOMYCIN;
SULFONE;
ANTIBIOTIC RESISTANCE;
BACTERIAL CELL WALL;
BACTERIAL GENETICS;
BACTERIAL GROWTH;
BACTERIAL METABOLISM;
BACTERICIDAL ACTIVITY;
BIOSYNTHESIS;
CELL STRUCTURE;
CHEMOTHERAPY;
DRUG EFFICACY;
DRUG POTENCY;
DRUG RESEARCH;
DRUG TARGETING;
FUTUROLOGY;
GLYCOPROTEIN SYNTHESIS;
HUMAN;
INFECTION RESISTANCE;
MEMBRANE BIOLOGY;
MOLECULAR EVOLUTION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN TARGETING;
SACCULUS;
SHORT SURVEY;
ANTI-BACTERIAL AGENTS;
BACTERIA;
CELL WALL;
DRUG DESIGN;
HUMANS;
PEPTIDOGLYCAN;
|
EID: 33645084237
PISSN: 09288244
EISSN: 1574695X
Source Type: Journal
DOI: 10.1111/j.1574-695X.2005.00032.x Document Type: Short Survey |
Times cited : (3)
|
References (25)
|